MASCC 2016 | Asian survey on oral mucositis

Jeeve Kanagalingam, MD of Mount Elizabeth Novena Hospital, Singapore, discusses oral mucositis investigations. Looking at patient and physician perspectives of oral mucositis, survey done in six countries in Asia, interviewed patients who suffered from oral mucositis as well as their physicians. The study shows that there is a very poor prevention of oral mucositis. Secondly, study results show very poor early detection, and thirdly there is huge misalignment between what patients think is important and what physicians think is important. The general perception amongst physicians is that there is a lack of effective remedies for this condition. Dr Kanagalingam mentions in the Asian context two major unmet needs. The most interesting approach is developing an in-clinic screener which allows the patient and the physician to recognize the problem early on and start intervention. Products are currently under development to help with this condition, however at early stages. Dr. Kanagalingam believes it is important to get basic oral care and hygiene done before treatment has started. Povidone iodine is a particular intervention being explored. There is good evidence that it has an anti-inflammatory and anti-microbial effect. Dr. Kanagalingam is optimistic about it having some sort of preventative and therapeutic effect for mucositis. He concludes that for all of mucositis, early recognition and prophylaxis is necessary and strong trials are required to compare the different products available so that patients can receive guidance in terms of what treatment is best. Recorded at the Multinational Association of Supportive Care in Cancer (MASCC) and International Society of Ocular Oncology (ISOO) 2016 Annual Meeting on Supportive Care in Cancer held in Adelaide, Australia.